post-add

Articles for Finance

Fortis Healthcare Reports Strong Q2 FY24 Financials, Agilus Diagnostics Files IPO

Fortis Healthcare showcased an improvement in net debt to EBITDA, standing at 0.29 compared to 0.44 annually for Q2 FY24 and Q2 FY23

Read More
Biocon Achieves 52% YoY Revenue Growth In Q2FY24

The Core EBITDA recorded a commendable 35 per cent YoY growth, reaching Rs 1,100 crore

Read More
Artemis Medicare Services Records Impressive Q2 FY24 Results With 21% YoY Growth In Revenue

The company, operating 713 beds primarily in the Delhi NCR region, reported a consolidated gross revenue of Rs. 2,376 million, marking a substantial 21.0 per cent increase

Read More
HCG Records Strong Growth In Q2 FY24 With 15.9% YoY Revenue Increase

In Q2 FY24, HCG achieved consolidated income from operations (Revenue) of Rs 4,869 million, marking a substantial 15.9 per cent year-on-year (YoY) growth and a 5.7 per cent quarter-on-quarter (QoQ) growth

Read More
Eris Lifesciences Reports Strong Q2 FY24 Financial Performance With 9.7 per cent YoY Increase In Revenue

The company reported a profit after tax (PAT) of Rs 1,223 million in Q2 FY24

Read More
Biocon Biologics To Divest Dermatology & Nephrology Units To Eris Lifesciences

The transaction, valued at Rs 3,660 million, inclusive of working capital, signifies a favourable multiple of 4 times on Revenues and 22 times on EBITDA

Read More
Yatharth Hospital Reports Q2 FY24 Performance With 70% PAT Growth

For the second quarter of the fiscal year 2024, Revenue from Operations reached a remarkable Rs. 1,713 million, representing a substantial 34 per cent year-on-year (YoY) increase

Read More
Alembic Pharmaceuticals Reports 8% Growth In Q2 FY24

In the second quarter, Alembic reported a notable 8 per cent increase in net sales, amounting to Rs. 1,595 crores while its net profit for the quarter reached Rs. 137 crores

Read More

Subscribe to our newsletter to get updates on our latest news